OPNT - Opiant Pharmaceuticals Inc. (OPNT) CEO Dr. Roger Crystal on Q1 2022 Results - Earnings Call Transcript

Opiant Pharmaceuticals, Inc. (OPNT) Q1 2022 Results Conference Call May 10, 2022 04:30 PM ET Company Participants Ben Atkins - Vice President, Communications and Investor Relations Dr. Roger Crystal - Chief Executive Officer Dr. Phil Skolnick - Chief Scientific Officer David O'Toole - Chief Financial Officer Matt Ruth - Chief Commercial Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Leland LelGershell - Oppenheimer David Bautz - Zacks Presentation Operator Greetings, and welcome to Opiant Pharmaceuticals First Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Ben Atkins, Vice President of Communications and Investor Relations. Thank you, and over to you. Ben Atkins Thank you, operator, and thank you all for joining us

For further details see:

Opiant Pharmaceuticals, Inc. (OPNT) CEO Dr. Roger Crystal on Q1 2022 Results - Earnings Call Transcript